Previous studies have demonstrated that PTEN/protein kinase-B (AKT) signaling pathway was usually overactivated in osteosarcoma and promoted the tumorigenesis and progression of osteosarcoma [17,18]. The gene discussed is PTEN; the disease is osteosarcoma.